SCHEMBL6394698

SCHEMBL6394698

CC(CC(=O)c1cc(O)ccc1P(=O)(O)O)c1cccc(O)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 4/20 0.36
LMNA P02545 3/20 0.36
KDM4E B2RXH2 2/20 0.36
ADRB1 P08588 2/20 0.36
ADRA1A P35348 2/20 0.36
MIF P14174 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2B P41595 1/20 0.36
ADRB2 P07550 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRB3 P13945 1/20 0.35
TSHR P16473 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
NFKB1 P19838 1/20 0.35
DRD1 P21728 1/20 0.35
HTR7 P34969 1/20 0.35
ADRA1B P35368 1/20 0.35
DRD3 P35462 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6395002 0.90 HIF1A (0.36) HIF1ALMNAKDM4EADRB1ADRA1A
SCHEMBL6397684 0.88 ESR1 (0.38) MIFOPRM1ESR1ESR2CA12
SCHEMBL6399853 0.81 ABCB1 (0.39) HIF1ALMNAKDM4EADRB1ADRA1A
SCHEMBL6394689 0.81 HIF1A (0.34) HIF1ALMNAKDM4EADRB1ADRA1A
SCHEMBL6401994 0.81 HDAC4 (0.39) HIF1ALMNAKDM4EADRB1ADRA1A
SCHEMBL6399197 0.80 MAPT (0.40) HIF1ALMNAKDM4EADRB1ADRA1A
SCHEMBL6394995 0.80 HIF1A (0.35) HIF1ALMNAKDM4EADRB1ADRA1A
SCHEMBL6399427 0.80 FFAR1 (0.35) HIF1ALMNAKDM4EADRB1ADRA1A
SCHEMBL6396879 0.79 MEN1 (0.36) HIF1ALMNAKDM4EADRB1ADRA1A
SCHEMBL6401143 0.77 ESR1 (0.38) MIFESR1ESR2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans PEERCE BRIAN E (US) 2005-08-25 US disclosed
US-6787528-B2 THERAPY FOR KIDNEY DISEASES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2004-09-07 US disclosed
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2003-08-28 US disclosed
US-20020133036-A1 Inhibitors of intestinal apical membrane Na/phosphate co-transportation PEERCE BRIAN E (US) 2002-09-19 US disclosed
US-6355823-B1 MEMBRANE SUBSTRATE PHOSPHATED FOR DRUGS FOR GASTROINTESTINAL DISORDERS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2002-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 HIF1A 2486/4885LMNA 4647/4885KDM4E 4601/4885
US-20020133036-A1 Inhibitors of intestinal apical membrane Na/phosphate co-transportation SLC10A2, SLC34A3, SLC34A1 HIF1A 2670/4885LMNA 4664/4885KDM4E 4500/4885
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 HIF1A 2486/4885LMNA 4647/4885KDM4E 4601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.